Ellen Pratt
Allergy & Immunology · Quincy, ILNPI 1255421533
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $48,773 of the $73,356 with a category attached, or 66.5%. CSL Behring accounts for 98.1% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $30,189 and has fallen 80.3% since, to $5,936 in 2025. Among allergy & immunology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 210 payments — averaging $349.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Behring$72K
- Sanofi$431
- Regeneron Healthcare Solutions, Inc.$153
- GSK$140
- AbbVie$136
- AstraZeneca$107
- plus $441 from 8 others
What the payments were for
- Consulting fees$4,2576%
- Speaking & faculty fees$48,77366%
- Travel & lodging$16,36322%
- Food & beverage$3,7315%
- Education$2320%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Behring | 159 | $71,947 |
| Sanofi | 13 | $431 |
| Regeneron Healthcare Solutions, Inc. | 6 | $153 |
| GSK | 7 | $140 |
| AbbVie | 5 | $136 |
| AstraZeneca | 6 | $107 |
| Novartis | 4 | $103 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| ARS Pharmaceuticals Operations, Inc. | 3 | $69 |
| Alk-abello, Inc | 1 | $68 |
| Genentech USA, Inc. | 2 | $42 |
| Lilly USA, LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Verona Pharma, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$73,356 in reported general payments places this provider in the 90th percentile of 161 allergy & immunology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Epinephrine | 27 | $5,817 |
| Azelastine Hcl | 56 | $1,934 |
| Fluticasone Propionate | 47 | $655 |
| Ipratropium Bromide | 13 | $283 |
| Famotidine | 53 | $247 |
| Levocetirizine Dihydrochloride | 12 | $155 |
| Azithromycin | 11 | $110 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in Quincy
- Dareen SiriNormal$1.5M
- Priya BansalSaint Charles$1.3M
- Anju PetersChicago$563K
- Giselle MosnaimChicago$331K
- Patrick WinShiloh$258K
- Amanda SalihChicago$160K
- Rebecca HoffmanWilmette$160K
- Juanita MoraChicago$147K
- Sonali MajmudarAlgonquin$136K
- Zachary RubinElmhurst$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.